A detailed history of New Mexico Educational Retirement Board transactions in Exelixis, Inc. stock. As of the latest transaction made, New Mexico Educational Retirement Board holds 66,200 shares of EXEL stock, worth $2.38 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
66,200
Previous 66,200 -0.0%
Holding current value
$2.38 Million
Previous $1.49 Million 15.46%
% of portfolio
0.06%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$20.17 - $23.93 $30,255 - $35,895
1,500 Added 2.32%
66,200 $1.57 Million
Q1 2024

Apr 17, 2024

SELL
$20.17 - $23.93 $30,255 - $35,895
-1,500 Reduced 2.27%
64,700 $1.47 Million
Q2 2023

Jul 17, 2023

BUY
$18.17 - $20.48 $141,726 - $159,744
7,800 Added 13.36%
66,200 $1.27 Million
Q1 2023

May 03, 2023

BUY
$16.3 - $19.41 $130,400 - $155,280
8,000 Added 15.87%
58,400 $1.13 Million
Q2 2022

Jul 21, 2022

SELL
$17.44 - $23.16 $249,392 - $331,188
-14,300 Reduced 22.1%
50,400 $1.05 Million
Q2 2021

Jul 13, 2021

BUY
$17.95 - $25.56 $188,475 - $268,380
10,500 Added 19.37%
64,700 $1.18 Million
Q4 2020

Feb 02, 2021

SELL
$18.39 - $24.8 $165,510 - $223,200
-9,000 Reduced 14.24%
54,200 $1.09 Million
Q3 2020

Oct 28, 2020

BUY
$20.67 - $26.94 $233,571 - $304,422
11,300 Added 21.77%
63,200 $1.55 Million
Q3 2020

Oct 27, 2020

SELL
$20.67 - $26.94 $423,735 - $552,270
-20,500 Reduced 28.31%
51,900 $918,000
Q1 2020

Jun 11, 2020

BUY
$14.46 - $21.8 $296,430 - $446,900
20,500 Added 39.5%
72,400 $1.25 Million
Q2 2019

Aug 06, 2019

SELL
$18.93 - $24.75 $159,012 - $207,900
-8,400 Reduced 13.93%
51,900 $1.11 Million
Q4 2018

Jan 28, 2019

SELL
$13.65 - $21.8 $81,900 - $130,800
-6,000 Reduced 9.05%
60,300 $1.19 Million
Q3 2018

Nov 19, 2018

BUY
$15.87 - $22.4 $1.05 Million - $1.49 Million
66,300 New
66,300 $1.18 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.6B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track New Mexico Educational Retirement Board Portfolio

Follow New Mexico Educational Retirement Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Mexico Educational Retirement Board, based on Form 13F filings with the SEC.

News

Stay updated on New Mexico Educational Retirement Board with notifications on news.